REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278,904 | +24.5% | 10,076 | +20.3% | 0.01% | +37.5% |
| Q2 2023 | $224,031 | +52.4% | 8,375 | +23.4% | 0.01% | +33.3% |
| Q1 2023 | $147,028 | -8.4% | 6,788 | +16.3% | 0.01% | 0.0% |
| Q4 2022 | $160,428 | +39.5% | 5,838 | 0.0% | 0.01% | +20.0% |
| Q3 2022 | $115,000 | +27.8% | 5,838 | +25.4% | 0.01% | +25.0% |
| Q2 2022 | $90,000 | -24.4% | 4,657 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $119,000 | +1.7% | 4,657 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $117,000 | -8.6% | 4,657 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $128,000 | -13.5% | 4,657 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $148,000 | -6.9% | 4,657 | +34.1% | 0.01% | -16.7% |
| Q1 2021 | $159,000 | +22.3% | 3,474 | +5.7% | 0.01% | 0.0% |
| Q4 2020 | $130,000 | +14.0% | 3,287 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $114,000 | +192.3% | 3,287 | +169.4% | 0.01% | +150.0% |
| Q2 2020 | $39,000 | +44.4% | 1,220 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $27,000 | – | 1,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |